Viveve to Host Conference Call on November 12, 2020 to Report Third Quarter Financial Results and Provide Corporate Update Nov 5, 2020
Viveve Announces Positive Primary Efficacy Data from its SUI Feasibility Study and Positive Preclinical Outcomes that Support the Company’s New Sham Tip for Pivotal PURSUIT Trial Aug 25, 2020
